Symphony Asset Management’s PharMerica Corporation PMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-13,303
Closed -$374K 474
2016
Q3
$374K Buy
13,303
+4,881
+58% +$125K 0.04% 315
2016
Q2
$208K Sell
8,422
-1,292
-13% -$32.1K 0.02% 346
2016
Q1
$214K Sell
9,714
-150
-2% -$3.99K 0.02% 359
2015
Q4
$345K Sell
9,864
-6,845
-41% -$214K 0.04% 339
2015
Q3
$476K Buy
16,709
+6,893
+70% +$232K 0.06% 322
2015
Q2
$327K Sell
9,816
-4,559
-32% -$140K 0.04% 337
2015
Q1
$405K Sell
14,375
-16,069
-53% -$399K 0.05% 373
2014
Q4
$631K Buy
+30,444
New +$723K 0.08% 209

Other funds holding PMC

Symphony Asset Management's PMC Position: Q4 2016 in Review

Symphony Asset Management sold out of PharMerica Corporation (PMC) in Q4 2016, closing a stake of 13,303 shares — an estimated $374K sold.

Symphony Asset Management first reported a position in PMC in Q4 2014 and held it in 8 quarters. The position peaked at $631K in Q4 2014. 166 funds tracked by Wall St. Rank hold PMC as of Q4 2016.

  • Symphony Asset Management reported no remaining PharMerica Corporation position as of Q4 2016 after selling out during the quarter.
  • Symphony Asset Management sold 13,303 PharMerica Corporation shares in Q4 2016, an estimated $374K.
  • Symphony Asset Management first reported a position in PharMerica Corporation in Q4 2014 and held it in 8 quarters.
  • Symphony Asset Management's PharMerica Corporation position peaked at $631K in Q4 2014.
  • 166 funds tracked by Wall St. Rank held PharMerica Corporation as of Q4 2016.

Based on Symphony Asset Management's 13F filing for Q4 2016, filed 14 Feb 2017.